Clean Intermittent Catheterization clinical trials

Explore recruiting clean intermittent catheterization clinical trials.

Recruiting clean intermittent catheterization studies right now

Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Clean Intermittent Catheterization trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

Lithuania, Croatia, Latvia, Denmark, Romania, Belgium +3 more

Phase II and Phase III (Integrated) EU CTIS Study details

Clean Intermittent Catheterization trials by city

Clean Intermittent Catheterization clinical trials

Recruiting clean intermittent catheterization studies right now

Effect of Mobile Application- and AI Supported Video-Based Patient Education on Patient Outcomes in Teaching Clean Intermittent Catheterization

Dose Escalation Study of EG110A, Administered by Intradetrusor Injections to Adults With Neurogenic Detrusor Overactivity-related Incontinence Following Spinal Cord Injury Who Regularly Perform Clean Intermittent Catheterization

Open-label, Long-term Safety, Efficacy, and Pharmacokinetics Study of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age With NDO and on CIC

Also recruiting in Europe

A Phase 2/3, Open-label, Baseline-controlled, Multicenter, Long-term Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of Vibegron in Pediatric Subjects 2 Years to < 18 Years of Age with Neurogenic Detrusor Overactivity (NDO) on Clean Intermittent Catheterization (CIC)

Clean Intermittent Catheterization trials by city

Other conditions